| Literature DB >> 35518538 |
Atif Nazir1, Khurram Niazi1, Syed Muhammad Jawad Zaidi2, Muhammad Ali1, Saeed Maqsood3, Jahanzeb Malik4, Mehwish Kaneez2, Amin Mehmoodi5.
Abstract
Central venous catheterization plays a key role in patients that require immediate resuscitation, long-term fluid management, and invasive monitoring. The supraclavicular (SC) and infraclavicular (IC) approaches are utilized for central venous catheterization and both have their benefits and limitations. In this systematic review, we aim to explore the success rate and various complications of the SC technique. A literature review was conducted on the PubMed, EMBASE, Scopus, CINAHL, and Cochrane databases. All relevant original articles that evaluated success rates and complications of SC access were retrieved and included for qualitative synthesis. After screening 1040 articles, 28 studies were included for further analysis. The overall success rate of SC access ranged between 79% and 100%. The overall complication rate in SC access ranged between 0% and 24.24% (Mean: 4.27%). The most prevalent complication was arterial puncture (1.39%) followed by catheter malposition (0.42%). The SC approach can be used as an alternative to the IC technique because of its low access time and high success rate. The SC approach should be more commonly used in day-to-day central venous cannulation. Further studies on the role of ultrasound guidance are warranted for the SC approach.Entities:
Keywords: central venous line; central venous pressure; critical care; landmark technique; subclavian vein
Year: 2022 PMID: 35518538 PMCID: PMC9063609 DOI: 10.7759/cureus.23781
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1PRISMA flow chart
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Baseline study characteristics and outcomes
* Study quality assessed by National Heart, Lung, and Blood Institute quality assessment tools. A score of 0-4 was labeled as poor, 4-7 as fair, and >7 as good quality studies.
Not reported (NR); randomized controlled trial (RCT)
| Author | Year | Study design | Controls | Sample size (for supraclavicular access); n | Success rate (Supraclavicular vs. Infraclavicular); % | Access time (min); mean ± Standard deviation | Overall complication rate; % | Malposition; n (%) | Pneumothorax; n (%) | Arterial puncture; n (%) | Hematoma; n (%) | Infection; n (%) | Thrombosis; n (%) | Obstruction; n (%) | Study quality* |
| Yoffa et al. [ | 1965 | Case series | None | 130 | 97.69 | NR | 0.76 | NR | 0 (0) | 1 (0.76) | 0 (0) | NR | NR | NR | 6 |
| Defalque et al. [ | 1970 | Prospective cohort | None | 1500 | 99 | NR | 0.46 | NR | 3 (0.20) | 4 (0.26) | NR | NR | NR | NR | 6 |
| Haapaniemi et al. [ | 1974 | Case series | None | 600 | 93.66 | NR | 1.5 | 10 (1.66) | 2 (0.33) | 4 (0.66) | NR | 3 (0.5) | NR | NR | 7 |
| Brahos et al. [ | 1977 | Case series | None | 100 | 96 | NR | 2 | 1 (1) | 1 (1) | 1 (1) | NR | NR | NR | NR | 7 |
| Brahos et al. [ | 1981 | Case series | None | 400 | 100 | NR | 0.75 | 3 (0.75) | 2 (0.5) | 1 (0.25) | NR | NR | NR | NR | 6 |
| Dronen et al. [ | 1982 | Case series | Infraclavicular access | 44 | 90.9 vs. 84.44 | NR | 2.27 | 3 (6.81) | 0 (0) | 1 (2.27) | NR | NR | NR | NR | 5 |
| Helmkamp et al. [ | 1985 | Case series | None | 99 | 90.9 | NR | 9 | 3 (3) | 3 (3) | NR | NR | 3 (3) | NR | 3 (3) | 4 |
| Sterner et al. [ | 1986 | RCT | Infraclavicular access | 245 | 84.48 | NR | 1.62 | 1 (0.4) | 2 (0.81) | 2 (0.81) | NR | NR | NR | NR | 6 |
| Nessler e al. [ | 1987 | Prospective cohort | None | 9,042 | 97.3 | NR | 1.62 | 10 (0.11) | 17 (0.18) | 131 (1.44) | NR | NR | NR | NR | 7 |
| Jones et al. [ | 1992 | Case series | None | 34 | 79.41 | NR | 23.48 | 2 (5.88) | 0 (0) | 7 (20.58) | NR | 1 (2.9) | 0 (0) | 0 (0) | 6 |
| Muhm et al. [ | 1997 | Prospective cohort | None | 208 | 94.71 | NR | 3.84 | 2 (0.96) | 1 (0.48) | 7 (3.36) | 0 (0) | NR | NR | NR | 6 |
| Nevarre et al. [ | 1997 | Prospective cohort | None | 178 | 97.8 | NR | 0.56 | 1 (0.56) | 1 (0.56) | NR | NR | NR | NR | NR | 6 |
| Apsner et al. [ | 1998 | Prospective cohort | None | 80 | 97.5 | NR | 8.6 | 3 (3.7) | 1 (1.2) | 3 (3.7) | NR | 2 (2.5) | 1 (1.2) | NR | 5 |
| Pittiruti et al. [ | 2000 | Retrospective | Infraclavicular, internal jugular, external jugular, and femoral access | 847 | NR | NR | 4.64 | 12 (1.4) | 9 (1.1) | 30 (3.54) | NR | NR | NR | NR | 6 |
| Czarnik et al. [ | 2009 | Prospective cohort | None | 370 | 88.9 | NR | 1.7 | NR | 0 (0) | 3 (0.8) | 0 (0) | NR | NR | NR | 6 |
| Pathiraja et al. [ | 2009 | Prospective cohort | None | 48 | 97.9 | NR | 4 | 1 (2.1) | 1 (2.1) | 0 (0) | 0 (0) | 1 (2.1) | NR | NR | 4 |
| Kocum et al. [ | 2011 | RCT | Infraclavicular, jugular access | 65 | 98 vs. 98 | NR | 0 | 4 (2.1) | 0 (0) | 0 (0) | 0 (0) | NR | NR | NR | 6 |
| Hussain et al. [ | 2011 | Prospective cohort | Infraclavicular access | 72 | 95.83 vs. 87.5 | NR | 5.6 | 2 (2.8) | 1 (1.4) | 3 (4.2) | NR | NR | NR | NR | 6 |
| Aziz et al. [ | 2013 | RCT | Infraclavicular access | 69 | 92.8 vs. 78.3 | NR | NR | NR | NR | NR | NR | NR | NR | NR | 4 |
| Thakur et al. [ | 2014 | RCT | Infraclavicular access | 30 | 96.99 vs. 90 | 4.3 ± 1.02 | 3.33 | NR | 0 (0) | 1 (3.33) | NR | NR | NR | NR | 4 |
| Prasad et al. [ | 2015 | Case series | None | 50 | 88 | 4.8 ± 1.02 | 4 | NR | 0 (0) | 2 (4) | NR | NR | NR | NR | 6 |
| Momin et al. [ | 2017 | RCT | Infraclavicular access | 25 | 92 vs. 80 | 5.3 ± 1.02 | 4 | 0 (0) | 0 (0) | NR | 1 (4) | NR | NR | NR | 5 |
| Tarbiat et al. [ | 2018 | RCT | Infraclavicular access | 140 | 94.3 vs. 97.1 | NR | 24.24 | 3 (2.14) | 3 (2.14) | 4 (2.8) | 27 (19.3) | NR | NR | NR | 5 |
| Souadka et al. [ | 2020 | Retrospective | Infraclavicular access | 70 | 97.25 vs. 86.2 | 23 ± 8 | 2.84 | NR | 0 (0) | NR | 1 (1.42) | 1 (1.42) | 0 (0) | 0 (0) | 6 |
| Prasad et al. [ | 2020 | c | Infraclavicular access | 55 | 100 vs. 100 | 2.96 ± 0.20 | NR | 2 (3.63) | NR | NR | NR | NR | NR | NR | 7 |
| Javed et al. [ | 2020 | Prospective cohort | Infraclavicular access | 51 | 98 vs. 82.35 | 4.44 ± 1.07 | 3.92 | NR | 0 (0) | NR | 2 (3.92) | 0 (0) | 0 (0) | NR | 6 |
| Khapung et al. [ | 2020 | RCT | Infraclavicular access | 35 | 100 vs. 88.57 | 1.9 ± 1.68 | 2.85 | NR | 0 (0) | 0 (0) | 1 (2.85) | NR | NR | NR | 7 |
| Kim et al. [ | 2021 | RCT | Infraclavicular access | 200 | 99.5 vs. 99.5 | Median (Interquartile range): 9 (6–20) | 2 | 2 (1) | 0 (0) | 4 (2) | 0 (0) | NR | NR | NR | 7 |
Figure 2Comparison of access time between the supraclavicular and infraclavicular approaches
Figure 3Surface anatomy of the neck indicating the procedure for inserting a central venous catheter into the subclavian vein via the supraclavicular approach
The needle indicates the direction in which the access should be obtained.
(1) Clavicular head of sternocleidomastoid, (2) sternal head of sternocleidomastoid, (3) manubrium, (4) right brachiocephalic vein, (5) right subclavian vein, (6) clavicle